Breath Therapeutics Announces Initiation of Global Phase 3 Trials for the Treatment of Bronchiolitis Obliterans Syndrome - P&T Community

Breath Therapeutics Announces Initiation of Global Phase 3 Trials for the Treatment of Bronchiolitis Obliterans Syndrome  P&T Community

MUNICH and MENLO PARK, Calif., March 26, 2019 /PRNewswire/ -- Breath Therapeutics, a private company developing advanced inhaled therapeutics in ...